发明名称 Use of YSCF, truncated YSCF and YSCF homologs as adjuvants
摘要 An antigenic composition comprising an antigen and an effective adjuvant, the adjuvant comprising isolated or recombinant YscF, a YscF fragment, truncated YscF (trYscF), or homologs thereof. A method of inducing an enhanced immune response comprising administering an antigen and an effective adjuvant comprising isolated or recombinant YscF, a YscF fragment, trYscF, or homologs thereof. An antigenic composition produced by a process comprising providing a host cell with an expression vector containing a nucleotide sequence encoding YscF, a YscF fragment, trYscF, or YscF homolog capable of acting as an adjuvant; expressing the nucleotide sequence in the host cell to produce the protein; and mixing the collected protein with a suitable excipient.
申请公布号 US9211327(B2) 申请公布日期 2015.12.15
申请号 US201214126405 申请日期 2012.06.22
申请人 University of North Dakota 发明人 Nilles Matthew
分类号 A61K39/00;A61K39/39;G01N33/50;A61K39/02 主分类号 A61K39/00
代理机构 TraskBritt, P.C. 代理人 TraskBritt, P.C.
主权项 1. A composition comprising: an antigen and an effective adjuvanting amount of recombinant Type III needle protein, wherein the Type III needle protein comprises an effective fragment of YscF protein.
地址 Grand Forks ND US